Children prescribed GLP-1 medications for weight loss, prediabetes, or type 2 diabetes are at risk for nutritional deficiencies, according to a new study published in the journal Childhood Obesity.

Monsanto has urged a Missouri judge to approve a proposed $7.25 billion Roundup settlement that could resolve nearly all current and future U.S. cancer claims against the company, telling the court there is no other negotiated deal waiting if the agreement falls apart.

Cefepime is a fourth-generation antibiotic widely used to treat serious bacterial infections and febrile neutropenia – a fever in patients with abnormally low white blood cell counts. However, scientists are concerned that this widely effective antibiotic may increase the risk of death.

A Novartis drug designed to lower levels of Lp(a), a known cardiovascular risk factor, failed to reduce patients’ risk of a heart attack, stroke, or other major cardiovascular events in the first late-stage test for a drug meant to tackle the mysterious molecule.

Two common GLP-1 weight-loss drugs have been linked to a brain condition that can cause permanent brain damage and become deadly.

Nearly eight million people across the UK are now taking five or more prescription medicines every day, fueling what clinicians describe as an overprescribing epidemic that is sending around 1,000 older people a day to hospital emergency departments with adverse drug reactions.

Novartis says it paused eight clinical trials of an experimental cell therapy targeting autoimmune and neurological disorders in late August, after three patients died.

Millions of patients who take popular blood pressure medication may be at risk of developing deadly kidney problems, experts have warned.